Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
3.910
-0.090 (-2.25%)
Oct 10, 2025, 1:36 PM EDT - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $2.19 million as of October 10, 2025. Its market cap has decreased by -65.75% in one year.
Market Cap
2.19M
Enterprise Value
5.55M
1-Year Change
-65.75%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $2.19M, a decrease of -98.52%. That is a compound annual growth rate of -60.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 2.23M | -30.71% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.88B |
| Johnson & Johnson | 460.19B |
| AbbVie | 407.53B |
| UnitedHealth Group | 333.01B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 232.02B |